Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An announcement from Lifecare AS ( (DE:LFC0) ) is now available.
Lifecare ASA has resolved to issue 12,000,000 new shares to the underwriters of its recently completed partially underwritten rights issue, as payment of underwriting commission at a subscription price of NOK 0.50 per share. This will increase the company’s share capital by NOK 1,200,000, with registration of the capital increase expected around 3 February 2026 and delivery of the new shares to underwriters around 4 February 2026. In addition, Lifecare will grant a total of 18,000,000 warrants to the underwriters, split evenly between two series with exercise windows in March and June 2026, a structure that both compensates underwriters and could lead to further equity inflows and dilution, supporting the company’s financing as it advances its medical sensor and continuous glucose monitoring ambitions.
More about Lifecare AS
Lifecare ASA is a medical sensor company specializing in technology for sensing and monitoring various body analytes, with a primary focus on bringing next-generation continuous glucose monitoring systems to market. The company’s osmotic pressure-based sensor technology is designed for use in humans and pets, enabling identification and monitoring of a broad range of analytes and molecules.
Average Trading Volume: 509,715
Current Market Cap: NOK143.2M
For detailed information about LFC0 stock, go to TipRanks’ Stock Analysis page.